This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Nishino, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takahashi, Y.
Right arrow Articles by Nishino, T.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 06 1997, 1326-1330, Vol 41, No. 6
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

In vitro activity of HSR-903, a new quinolone

Y Takahashi, N Masuda, M Otsuki, M Miki and T Nishino
Department of Microbiology, Kyoto Pharmaceutical University, Yamashina- ku, Japan.

The in vitro activity of the new fluoroquinolone HSR-903 was compared with those of ciprofloxacin, lomefloxacin, sparfloxacin, and levofloxacin. HSR-903 inhibited 90% of methicillin-susceptible and - resistant Staphylococcus aureus (MRSA) clinical isolates at 0.78 and 1.56 microg/ml, respectively, and its activity against MRSA was 16-fold higher than those of sparfloxacin and levofloxacin and 64-fold higher than that of ciprofloxacin. The MICs at which 90% of the isolates are inhibited (MIC90s) of HSR-903 for Streptococcus pyogenes and penicillin G-susceptible and -resistant Streptococcus pneumoniae (PRSP) were 0.10, 0.05, and 0.05 microg/ml, respectively. Against PRSP, the activity of HSR-903 was 4-fold higher than that of sparfloxacin and 32- to 256-fold higher than those of the other quinolones. The MIC90 of HSR-903 for Enterococcus faecalis was 0.20 microg/ml, and HSR-903 was more active than the other quinolones against enterococci. The activity of HSR-903 against members of the family Enterobacteriaceae and Pseudomonas aeruginosa was roughly similar to that of ciprofloxacin and greater than those of the other quinolones. Against Haemophilus influenzae, Moraxella catarrhalis, and Helicobacter pylori, HSR-903 was the most potent of the quinolones tested. The activity of HSR-903 was not affected by the medium, the inoculum size, or the addition of serum, but decreased under acidic conditions, as did those of the other quinolones tested. HSR-903 exhibited rapid bactericidal action and had a good postantibiotic effect on S. aureus and P. aeruginosa. HSR-903 inhibited supercoiling by DNA gyrase from Escherichia coli, but it was much less active against human topoisomerase II.


This article has been cited by other articles:

  • Miyazaki, S., Okazaki, K., Tsuji, M., Yamaguchi, K. (2004). Pharmacodynamics of S-3578, a Novel Cephem, in Murine Lung and Systemic Infection Models. Antimicrob. Agents Chemother. 48: 378-383 [Abstract] [Full Text]  
  • Higa, F., Arakaki, N., Tateyama, M., Koide, M., Shinzato, T., Kawakami, K., Saito, A. (2003). In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.. J Antimicrob Chemother 52: 920-924 [Abstract] [Full Text]  
  • Drago, L., De Vecchi, E., Mombelli, B., Nicola, L., Valli, M., Gismondo, M. R. (2001). Activity of levofloxacin and ciprofloxacin against urinary pathogens. J Antimicrob Chemother 48: 37-45 [Abstract] [Full Text]  
  • Yoshizumi, S., Takahashi, Y., Murata, M., Domon, H., Furuya, N., Ishii, Y., Matsumoto, T., Ohno, A., Tateda, K., Miyazaki, S., Yamaguchi, K. (2001). The in vivo activity of olamufloxacin (HSR-903) in systemic and urinary tract infections in mice. J Antimicrob Chemother 48: 137-140 [Abstract] [Full Text]  
  • Sanchez, J. E. G., Saenz, N. G., Rincon, M. R., Martin, I. T., Sanchez, E. G., Martinez, M. J. F. (2000). Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin/dalfopristin and new quinolones. J Antimicrob Chemother 46: 283-285 [Abstract] [Full Text]  
  • Tomioka, H., Sato, K., Akaki, T., Kajitani, H., Kawahara, S., Sakatani, M. (1999). Comparative In Vitro Antimicrobial Activities of the Newly Synthesized Quinolone HSR-903, Sitafloxacin (DU-6859a), Gatifloxacin (AM-1155), and Levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium Complex. Antimicrob. Agents Chemother. 43: 3001-3004 [Abstract] [Full Text]  
  • Watanabe, A., Tokue, Y., Takahashi, H., Kikuchi, T., Kobayashi, T., Gomi, K., Fujimura, S., Nukiwa, T. (1999). In Vitro Activity of HSR-903, a New Oral Quinolone, against Bacteria Causing Respiratory Infections. Antimicrob. Agents Chemother. 43: 1767-1768 [Abstract] [Full Text]  
  • Murata, M., Tamai, I., Kato, H., Nagata, O., Kato, H., Tsuji, A. (1999). Efflux Transport of a New Quinolone Antibacterial Agent, HSR-903, across the Blood-Brain Barrier. J. Pharmacol. Exp. Ther. 290: 51-57 [Abstract] [Full Text]  
  • Niki, Y., Watanabe, S., Tamada, S., Yoshida, K., Miyashita, N., Nakajima, M., Matsushima, T., Sekino, H., Matsuoka, O. (1999). Effect of HSR-903, a New Fluoroquinolone, on the Concentration of Theophylline in Serum. Antimicrob. Agents Chemother. 43: 1494-1496 [Abstract] [Full Text]  
  • Murata, M., Tamai, I., Sai, Y., Nagata, O., Kato, H., Tsuji, A. (1999). Carrier-Mediated Lung Distribution of HSR-903, a New Quinolone Antibacterial Agent. J. Pharmacol. Exp. Ther. 289: 79-84 [Abstract] [Full Text]  
  • Murata, M., Tamai, I., Sai, Y., Nagata, O., Kato, H., Sugiyama, Y., Tsuji, A. (1998). Hepatobiliary Transport Kinetics of HSR-903, a New Quinolone Antibacterial Agent. Drug Metab. Dispos. 26: 1113-1119 [Abstract] [Full Text]  
  • Yoshizumi, S., Domon, H., Miyazaki, S., Yamaguchi, K. (1998). In Vivo Activity of HSR-903, a New Fluoroquinolone, against Respiratory Pathogens. Antimicrob. Agents Chemother. 42: 785-788 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»